Skip to content
10-Q

Quarterly Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-18-000958

← back to feed
Filed
May 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 10, 2018 9.7M sh
Current Liabilities Q1 2018 · Mar 31, 2018 $148K
Current Liabilities Q1 2018 · Dec 31, 2017 $134.23K
Total Liabilities Q1 2018 · Mar 31, 2018 $151.96K
Total Liabilities Q1 2018 · Dec 31, 2017 $134.23K
Current Assets Q1 2018 · Mar 31, 2018 $10.28K
Current Assets Q1 2018 · Dec 31, 2017 $4.69K
Total Assets Q1 2018 · Mar 31, 2018 $10.28K
Total Assets Q1 2018 · Dec 31, 2017 $4.69K
Sga Expense Q1 2018 · Mar 31, 2018 $2.2K
Sga Expense Q1 2018 · Mar 31, 2017 $1.23K
Gross Profit Q1 2018 · Mar 31, 2018 −$2.47K
Revenue Q1 2018 · Mar 31, 2018 $2.29K
Net Income Q1 2018 · Mar 31, 2017 −$3.73K
Operating Income Q1 2018 · Mar 31, 2017 −$3.73K